Kowalsky Matthew Paul
- SEC CIK
- 0001705824
No open-market purchases or sales filed in the past year.
Current role at each company
- ENTA Enanta Pharmaceuticals IncChief Legal Officeras of Feb 13, 2026
- SGTX Sigilon Therapeutics, Inc.CHIEF OF STAFF AND CLOas of Aug 11, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kowalsky Matthew Paul as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
No insider trades match these filters.